Home > Healthcare > Biotechnology > Biotechnology R&D > Cloning and Mutagenesis Market

Cloning and Mutagenesis Market Share

  • Report ID: GMI6030
  • Published Date: Jun 2023
  • Report Format: PDF

Cloning and Mutagenesis Market Share

Major market players operating in the cloning and mutagenesis market include

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Takara Bio Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Jena Bioscience GmbH
  • New England Biolabs
  • Promega Corporation
  • Assay Genie
  • TransGen Biotech Co., Ltd.
  • Genes2Me
  • GenScript
  • Genomax Technologies Pte Ltd 
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of cloning and mutagenesis was USD 2.9 billion in 2023 and is likely to expand at 19.4% CAGR from 2024 to 2032 driven by the growing focus on genetic engineering and rising demand for genetically modified products.

The cloning kits product segment held more than 53% of the Cloning and mutagenesis market share in 2022 and is expected to witness high demand for various applications in gene cloning, protein expression, genetic engineering, and DNA sequencing among others.

North America held over 38.6% of the cloning and mutagenesis industry share in 2022 and is estimated to expand further through 2032 owing to the presence of key market players in the region.

Few top firms engaged in the global market are Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Takara Bio Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Danaher, Jena Bioscience GmbH, New England Biolabs, Promega Corporation, and Assay Genie

Cloning and Mutagenesis Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 210
  • Countries covered: 20
  • Pages: 120
 Download Free Sample